Inaugural Health 2.0 Conference Is Harbinger of More to Come


Author: Neil Versel
SAN FRANCISCO — A slew of companies have some pretty lofty expectations in interactive health care media, otherwise known as “health 2.0.”

“We want to create an experience that’s basically a shopping.com for health,” says Chini Krishnan, founder and chief executive of Vimo, an online comparison-shopping site for insurance, health savings accounts, physicians, and dentists.

Others here for a first-of-its-kind conference (Health 2.0) on health 2.0 technologies and user-generated content in health care compared themselves to YouTube, Trip Advisor, and RateItAll — for health care, of course. Sure, some of it is hype for start-up companies, but many believe interactive media are here to stay.

“The Web has fixed a lot of broken industries. We think it’s time to do it with health care,” said Marty Tennenbaum, a pioneer in e-commerce in the early 1990s. Today, Tennenbaum is an investor in several private health 2.0 ventures, including a social and support network called PatientsLikeMe.

“Health 2.0 is just getting beyond being a buzzword,” said conference organizer Matthew Holt, an occasional contributor to Digital Health care & Productivity.

When top-tier “consumer aggregators” like Google, Yahoo, WebMD, and Microsoft — all represented on a conference panel — take note, there’s a pretty good chance it’s more than just a fringe movement, though it’s definitely early in the game.

Holt defined a four-step continuum of health 2.0: user-generated content; users connecting to health care providers; formation of partnerships to reform delivery; and finally, data driving discovery. Most players in this segment are in one of the first two stages.

“Consumers are still having trouble sorting through what’s trustworthy,” offered Google health product marketing manager Missy Krasner. “They need a coach. They need a trusted coach.”

WebMD CEO Wayne Gatinella agreed. “They don’t know enough to trust what they don’t know,” he said. “If we screw up the credibility part, everything else goes away.”

A lot of eyes in the room were on Google, since the company has been struggling to bring a health care product to market. (Notable for his presence at the meeting but his absence from the podium was Adam Bosworth, recently dismissed as corporate vice president and head of Google’s health team.)

Google has been relying on a small team of experts — mostly volunteers — to label health content as part of Google Scholar, which remains in beta more than a year after its debut. (See “Google Co-op for Health Gets Boost from PHR Expert Kibbe.”) “It’s certainly been an experiment,” Krasner said.

Other firms, large and small, are moving ahead with their own plans to improve certain areas of health care with interactive media. No less than half a dozen health-specific search engines made presentations or otherwise had a presence at last week’s San Francisco meeting, including some who believe the “Big Three” of Google, Yahoo, and MSN have lost their focus when it comes to health care.

Steven Krein, CEO of a newly launched search engine called OrganizedWisdom, believes general Web searches have become cluttered with “index spam” because results are indexed by computerized algorithms. “To have the No. 1 result be spam is mind-boggling. I don’t think that’s acceptable in 2007,” Krein said.

In health care, Krein wants a return to Yahoo circa 1996, when people did the indexing. “We believe that people plus algorithms makes better search,” he said.

Health 2.0 may have another parallel to the early days of the Web. “I see a completely fragmented approach,” said Jay Silverstein of Revolution Health, the service created by AOL co-founder Steve Case. “I advise many of you to hook up,” Silverstein told the many start-ups among the nearly 500 people in attendance.

When the second health 2.0 conference comes around next March, the landscape could be markedly different.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.